The role of splenectomy in management of splenic B-cell lymphomas
- 2 March 2023
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 128, 107053
Abstract
No abstract availableKeywords
Funding Information
- Hairy Cell Leukemia Foundation
This publication has 18 references indexed in Scilit:
- Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemiaBlood, 2017
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- Hairy cell leukaemia-variant: Disease features and treatmentBest Practice & Research Clinical Haematology, 2015
- Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research NetworkBritish Journal of Cancer, 2015
- Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphomaAnnals of Hematology, 2013
- Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With SplenectomyThe Oncologist, 2013
- Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphomaBritish Journal of Haematology, 2012
- The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphomaBritish Journal of Haematology, 2012
- Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological featuresHaematologica, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009